Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05863)

• Formulation Name: Didanosine 250 mg capsule
• Company: Bristol-Myers Squibb Company

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Didanosine	(DMI2QPE)	Human immunodeficiency virus infection	1C62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carboxymethylcellulose sodium	(E00621)	Not Available	Adsorbent; Binding agent; Disintegrant; Emulsifying agent; Suspending agent; Viscosity-controlling agent
Diethyl phthalate	(E00135)	6781	Plasticizing agent; Solvent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent